4th Annual Neuropsychiatric Drug Development Summit | September 29-30, 2021 | Digital Event
Evvnt Promotion / evvnt
Archiv
29.09.2021 - 30.09.2021 Online, USA
Time: 8:30 AM - 6:00 PM
Kongressthemen
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/791022-3?pid=4832
Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
Brochure: https://go.evvnt.com/791022-3?pid=4832
Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
Anfragen und Anmeldung:
https://go.evvnt.com/791022-2?pid=4832
Herr Customer Service
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
